GRI Bio, Inc
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GRI Bio, Inc and other ETFs, options, and stocks.About GRI
GRI Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for inflammatory, fibrotic, and autoimmune diseases. It focuses on its lead program, GRI-0621, an inhibitor of type 1 invariant Natural Killer T (iNKT) cell activity and is being developed as a novel oral therapeutic for the treatment of idiopathic pulmonary fibrosis.
GRI Key Statistics
Stock Snapshot
As of today, GRI Bio, Inc(GRI) shares are valued at $0.21. The company's market cap stands at 2.84M, with a P/E ratio of -0.01.
On 2026-01-24, GRI Bio, Inc(GRI) stock traded between a low of $0.19 and a high of $0.22. Shares are currently priced at $0.21, which is +9.9% above the low and -2.9% below the high.
GRI Bio, Inc(GRI) shares are trading with a volume of 1.9M, against a daily average of 3.28M.
During the past year, GRI Bio, Inc(GRI) stock moved between $0.18 at its lowest and $11.90 at its peak.
During the past year, GRI Bio, Inc(GRI) stock moved between $0.18 at its lowest and $11.90 at its peak.
GRI News
Claim 50% Off TipRanks Premium GRI Bio ( (GRI) ) has shared an announcement. On January 21, 2026, GRI Bio, Inc. announced that its board and stockholders had...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.